Helus Pharma (HELP) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Helus Pharma (HELP) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.14 of bullish evidence against -0.28 bearish.

Helus Pharma last closed at $11.42, -2.39% on the session.

Against the IVW growth benchmark the position is -3.31% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

3 graded predictions for HELP so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Helus Pharma in the 14th percentile on return on equity, where 100 is best.

Helus Pharma is classified under Health Care / Pharmaceuticals, with a market capitalisation of $930.75M.

StockMap tracks Helus Pharma as the 56th largest of the 128 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Moderate Underperform, 53 Neutral, 15 Strong Underperform and 6 Moderate Outperform.

On that composite Helus Pharma ranks 70th of 128 in the group, against a group median of -0.24.